Strengths and Weaknesses of Using Conferencing Technologies to Support Drug Policy Knowledge Exchange. - Mowafa Said Househ; André Kushniruk; Malcolm Maclure; Bruce C. Carleton; Denise Cloutier-Fisher (ITCH, 2011)

The use of conferencing technologies to support drug policy group knowledge exchange processes: An action case approach. - Mowafa Said Househ; André Kushniruk; Malcolm Maclure; Bruce C. Carleton; Denise Cloutier-Fisher (Int. J. Medical Informatics, 2011)

A Literature Review on Distance Knowledge Exchange in Healthcare Groups: What Can We Learn From the ICT Literature? - Mowafa Said Househ; André Kushniruk; Bruce C. Carleton; Denise Cloutier-Fisher (J. Medical Syst., 2011)

Technology Enabled Knowledge Exchange: Development of a Conceptual Framework. - Mowafa Said Househ; André Kushniruk; Denise Cloutier-Fisher; Bruce C. Carleton (J. Medical Syst., 2011)

An in silico framework for integrating epidemiologic and genetic evidence with health care applications: ventilation-related pneumothorax as a case illustration. - Yelizaveta Torosyan; Yuzhi Hu; Sarah Hoffman; Qianlai Luo; Bruce C. Carleton; Danica Marinac-Dabic (J. Am. Medical Informatics Assoc., 2016)

HUME: large-scale detection of causal genetic factors of adverse drug reactions. - Mehrdad Mansouri; Bowei Yuan; Colin J. D. Ross; Bruce C. Carleton; Martin Ester (Bioinform., 2018)

Machine learning model identifies genetic predictors of cisplatin-induced ototoxicity in CERS6 and TLR4. - Ali Arab; Bahareh Kashani; Miguel Cordova-Delgado; Erika N. Scott; Kaveh Alemi; Jessica Trueman; Gabriella Groeneweg; Wan-Chun Chang; Catrina M. Loucks; Colin J. D. Ross; Bruce C. Carleton; Martin Ester (Comput. Biol. Medicine, 2024)